Cargando…

Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria

Introducing a new vaccine is a large-scale endeavor that can face many challenges, resulting in introduction delays and inefficiencies. The development of national task teams and tools, such as prelaunch trackers, for the introduction of new vaccines (hereafter, “new vaccine introductions” [NVIs]) c...

Descripción completa

Detalles Bibliográficos
Autores principales: Scotney, Soleine, Snidal, Sarah, Saidu, Yauba, Ojumu, Abiola, Ngatia, Antony, Bagana, Murtala, Mutuku, Faith, Sobngwi, Joelle, Efe-Aluta, Oniovo, Roper, Julia, LeTallec, Yann, Kang’ethe, Alice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853243/
https://www.ncbi.nlm.nih.gov/pubmed/28838156
http://dx.doi.org/10.1093/infdis/jiw544
_version_ 1783306728616493056
author Scotney, Soleine
Snidal, Sarah
Saidu, Yauba
Ojumu, Abiola
Ngatia, Antony
Bagana, Murtala
Mutuku, Faith
Sobngwi, Joelle
Efe-Aluta, Oniovo
Roper, Julia
LeTallec, Yann
Kang’ethe, Alice
author_facet Scotney, Soleine
Snidal, Sarah
Saidu, Yauba
Ojumu, Abiola
Ngatia, Antony
Bagana, Murtala
Mutuku, Faith
Sobngwi, Joelle
Efe-Aluta, Oniovo
Roper, Julia
LeTallec, Yann
Kang’ethe, Alice
author_sort Scotney, Soleine
collection PubMed
description Introducing a new vaccine is a large-scale endeavor that can face many challenges, resulting in introduction delays and inefficiencies. The development of national task teams and tools, such as prelaunch trackers, for the introduction of new vaccines (hereafter, “new vaccine introductions” [NVIs]) can help countries implement robust project management systems, front-load critical preparatory activities, and ensure continuous communication around vaccine supply and financing. In addition, implementing postlaunch assessments to take rapid corrective action accelerates the uptake of the new vaccines. NVIs can provide an opportunity to strengthen routine immunization, through strengthening program management systems or by reinforcing local immunization managers’ abilities, among others. This article highlights key lessons learned during the introduction of inactivated poliovirus vaccine in 3 countries that would make future NVIs more successful. The article concludes by considering how the Immunization Systems Management Group of the Global Polio Eradication Initiative has been useful to the NVI process and how such global structures could be further enhanced.
format Online
Article
Text
id pubmed-5853243
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-58532432018-03-23 Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria Scotney, Soleine Snidal, Sarah Saidu, Yauba Ojumu, Abiola Ngatia, Antony Bagana, Murtala Mutuku, Faith Sobngwi, Joelle Efe-Aluta, Oniovo Roper, Julia LeTallec, Yann Kang’ethe, Alice J Infect Dis Supplement Article Introducing a new vaccine is a large-scale endeavor that can face many challenges, resulting in introduction delays and inefficiencies. The development of national task teams and tools, such as prelaunch trackers, for the introduction of new vaccines (hereafter, “new vaccine introductions” [NVIs]) can help countries implement robust project management systems, front-load critical preparatory activities, and ensure continuous communication around vaccine supply and financing. In addition, implementing postlaunch assessments to take rapid corrective action accelerates the uptake of the new vaccines. NVIs can provide an opportunity to strengthen routine immunization, through strengthening program management systems or by reinforcing local immunization managers’ abilities, among others. This article highlights key lessons learned during the introduction of inactivated poliovirus vaccine in 3 countries that would make future NVIs more successful. The article concludes by considering how the Immunization Systems Management Group of the Global Polio Eradication Initiative has been useful to the NVI process and how such global structures could be further enhanced. Oxford University Press 2017-07-01 2017-06-30 /pmc/articles/PMC5853243/ /pubmed/28838156 http://dx.doi.org/10.1093/infdis/jiw544 Text en © The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Supplement Article
Scotney, Soleine
Snidal, Sarah
Saidu, Yauba
Ojumu, Abiola
Ngatia, Antony
Bagana, Murtala
Mutuku, Faith
Sobngwi, Joelle
Efe-Aluta, Oniovo
Roper, Julia
LeTallec, Yann
Kang’ethe, Alice
Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria
title Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria
title_full Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria
title_fullStr Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria
title_full_unstemmed Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria
title_short Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria
title_sort succeeding in new vaccine introduction: lessons learned from the introduction of inactivated poliovirus vaccine in cameroon, kenya, and nigeria
topic Supplement Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853243/
https://www.ncbi.nlm.nih.gov/pubmed/28838156
http://dx.doi.org/10.1093/infdis/jiw544
work_keys_str_mv AT scotneysoleine succeedinginnewvaccineintroductionlessonslearnedfromtheintroductionofinactivatedpoliovirusvaccineincameroonkenyaandnigeria
AT snidalsarah succeedinginnewvaccineintroductionlessonslearnedfromtheintroductionofinactivatedpoliovirusvaccineincameroonkenyaandnigeria
AT saiduyauba succeedinginnewvaccineintroductionlessonslearnedfromtheintroductionofinactivatedpoliovirusvaccineincameroonkenyaandnigeria
AT ojumuabiola succeedinginnewvaccineintroductionlessonslearnedfromtheintroductionofinactivatedpoliovirusvaccineincameroonkenyaandnigeria
AT ngatiaantony succeedinginnewvaccineintroductionlessonslearnedfromtheintroductionofinactivatedpoliovirusvaccineincameroonkenyaandnigeria
AT baganamurtala succeedinginnewvaccineintroductionlessonslearnedfromtheintroductionofinactivatedpoliovirusvaccineincameroonkenyaandnigeria
AT mutukufaith succeedinginnewvaccineintroductionlessonslearnedfromtheintroductionofinactivatedpoliovirusvaccineincameroonkenyaandnigeria
AT sobngwijoelle succeedinginnewvaccineintroductionlessonslearnedfromtheintroductionofinactivatedpoliovirusvaccineincameroonkenyaandnigeria
AT efealutaoniovo succeedinginnewvaccineintroductionlessonslearnedfromtheintroductionofinactivatedpoliovirusvaccineincameroonkenyaandnigeria
AT roperjulia succeedinginnewvaccineintroductionlessonslearnedfromtheintroductionofinactivatedpoliovirusvaccineincameroonkenyaandnigeria
AT letallecyann succeedinginnewvaccineintroductionlessonslearnedfromtheintroductionofinactivatedpoliovirusvaccineincameroonkenyaandnigeria
AT kangethealice succeedinginnewvaccineintroductionlessonslearnedfromtheintroductionofinactivatedpoliovirusvaccineincameroonkenyaandnigeria